Search

everythinglearnresearchcommunity

for

Search:↓

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Linagliptin slows down premature aging in certain mice.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

GLP-1 receptor agonists can cause skin and hair issues due to rapid weight loss, but these can be managed with proper care and treatments.

Voglibose may help treat skin hyperpigmentation safely.

TAT-GILZ peptide promotes hair growth by boosting stem cell activity.

GLP1-RAs may have higher reports of suicide and hair loss, but no strong evidence links them to these issues.

GLP-1 therapies, especially semaglutide and tirzepatide, may cause hair loss, particularly in women and with rapid weight loss.

GLP-1 receptor agonists can cause skin reactions, facial fat loss, and hair loss, but may help with wound healing and skin conditions.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Liraglutide with metformin reduces body fat and improves blood sugar control better than metformin and inositol in women with prediabetes.

Semaglutide is an effective weekly treatment for obesity, promoting weight loss and improving health, despite some side effects.

Newer GLP-1 drugs like semaglutide may cause hair loss.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

GLP-1 receptor agonists may cause hair loss, but more research is needed.

Biomimetic peptides improved hair growth and increased growth factors in hair follicles for hair loss patients.

Increasing Teneligliptin on his own caused a man's hair loss, which stopped when he ceased the medication.

GLP-1 receptor analogs may help improve metabolism and reproductive health in people with PCOS and obesity.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

The model successfully predicted new uses for existing drugs, like using certain hormonal and heart medications for respiratory and Parkinson's diseases, and a cancer drug for diabetes.

Peficitinib can turn human fibroblasts into cells that help grow hair.

Rebamipide may help regrow hair by activating hair follicle stem cells.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Letrozole may help prevent seizures by reducing certain hormone levels.

Bezafibrate treatment improved skin and spleen health in aging mice but didn't extend lifespan.

Drugs targeting EMT molecules show promise for treating lichen planopilaris.

Feeding sheep up to 30% Leucaena leaf meal does not harm their blood metabolites and thyroid hormones.